In March 2020, as the UK was preparing to go into lockdown, two new trials were posted on the clinicaltrials.gov database. The researchers were proposing that BCG, an old vaccine against tuberculosis (TB), should be tested for its protective effect against COVID.
As vaccines tend to activate very specific immune responses against their target disease, why did these scientists believe that BCG might have an effect against this profoundly different pathogen?
